Philipp Mathieu
Director/Board Member chez IMMUNOVIA AB
Provenance du réseau au premier degré de Philipp Mathieu
| Entité | Type d'entité | Industrie | |
|---|---|---|---|
24
| Public Company | Pharmaceuticals: Major | 24 |
Graphique Sociétés connectées au second degré
Relation dans plusieurs entreprises
Sociétés connectées à Philipp Mathieu via son réseau personnel
| Société | Secteur | Personnes liées | Poste principal |
|---|---|---|---|
Lundbeck Research USA, Inc.
 Lundbeck Research USA, Inc. Pharmaceuticals: MajorHealth Technology Lundbeck Research USA, Inc. develops pharmaceutical products and information to the medical community. The firm engages in the drug discovery aimed at treating central nervous system diseases by designing small molecule therapeutics. The company was founded in 1990 and is headquartered in Paramus, NJ. | Pharmaceuticals: Major | Chairman | |
| QIAGEN N.V. | Medical Specialties | General Counsel Compliance Officer | |
| NOVO NORDISK A/S | Pharmaceuticals: Major | Corporate Officer/Principal | |
| H. LUNDBECK A/S | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Dako Denmark ApS
 Dako Denmark ApS Medical SpecialtiesHealth Technology Dako Denmark A/S designs and manufactures cancer diagnostic systems. It produces reagents, antibodies, instruments, and software solutions to make diagnoses and determine treatments for patients suffering from cancer. The firm's product areas encompass Immunohistochemistry, pharmacoDiagnostics, molecular pathology, Hematoxylin and Eosin stain, special stains, flow Cytometry, and specific proteins. The company was founded by Niels Harboe in 1966 and is headquartered in Glostrup, Denmark. | Medical Specialties | Chief Executive Officer Chief Tech/Sci/R&D Officer | |
| Wallac Oy | Corporate Officer/Principal Corporate Officer/Principal | ||
Euro-Diagnostica AB
 Euro-Diagnostica AB Pharmaceuticals: MajorHealth Technology Euro-Diagnostica AB provides autoimmunity testing and diagnostic solutions. It facilitates the development of safe and efficient drugs and optimal treatment of patients by providing cutting edge assays. The firm also provides clinical labs and physicians with tools to aid in diagnosis, prognosis, monitoring, and treatment of inflammatory and related diseases. The company was founded in 1992 and is headquartered in Malmo, Sweden. | Pharmaceuticals: Major | General Counsel Corporate Officer/Principal | |
| Qiagen Finance (Luxembourg) SA | Finance/Rental/Leasing | Director/Board Member | |
| ALLIGATOR BIOSCIENCE AB | Biotechnology | Founder | |
| University of Uppsala | College/University | Graduate Degree | |
| ZEALAND PHARMA A/S | Pharmaceuticals: Major | Founder | |
| University of Hamburg | College/University | Graduate Degree | |
| University of Lund | College/University | Doctorate Degree Undergraduate Degree Doctorate Degree Graduate Degree Undergraduate Degree | |
| University of Copenhagen | College/University | Doctorate Degree Graduate Degree | |
Forbion Capital Partners Management Holding BV
 Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Investment Managers | Private Equity Investor | |
European Federation of Pharmaceutical Industries & Assns
 European Federation of Pharmaceutical Industries & Assns Miscellaneous Commercial ServicesCommercial Services The European Federation of Pharmaceutical Industries & Assns is a trade association that promotes pharmaceutical discovery and development. The non-profit company is based in Brussels, Belgium. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
Glycom A/S
 Glycom A/S BiotechnologyHealth Technology Glycom A/S engages in the development, synthesis, and commercialization of human milk oligosaccharides. It develops chemical and enzymatic technologies for synthesis of human milk oligosaccharide powders. The company was founded by Gyuala Dekany, Mark von Itzstein, Joachim Erich Thiem, Arnold Stutz, and Inge Lundt on March 22, 2005 and is headquartered in Horsholm, Denmark. | Biotechnology | Founder | |
| Collegium Internationale Neuro-Psychopharmacologicum | Corporate Officer/Principal | ||
Ysios Capital Partners SGEIC SA
 Ysios Capital Partners SGEIC SA Investment ManagersFinance Ysios Capital Partners SGEIC SA (Ysios Capital) is a venture capital firm founded in 2007 by Joël Jean Pierre Jean-Mairet, Julia Salaverría Monfort and Josep Lluís Sanfeliu Benet. The firm is headquartered in San Sabastian, Spain with additional office in Barcelona. | Investment Managers | Private Equity Investor | |
QIAGEN Aarhus A/S
 QIAGEN Aarhus A/S Packaged SoftwareTechnology Services QIAGEN Aarhus A/S develops and markets software and hardware solutions and consultancy services within bioinformatics. Its products include workbench, server solutions, database, and modules. The company was founded by Thomas Knudsen and Bjarne Knudsen in 2004 and is headquartered in Aarhus, Denmark. | Packaged Software | Director/Board Member | |
| QIAGEN MARSEILLE | Miscellaneous Commercial Services | Director/Board Member | |
ACADIA Pharmaceuticals A/S
 ACADIA Pharmaceuticals A/S Miscellaneous Commercial ServicesCommercial Services Part of ACADIA Pharmaceuticals, Inc., ACADIA Pharmaceuticals A/S utilizes technology to fuel drug discovery and clinical development. The private company is based in Glostrup, Denmark. The Danish company was founded by Peter Høngaard Andersen. | Miscellaneous Commercial Services | Founder | |
EpiTherapeutics ApS
 EpiTherapeutics ApS BiotechnologyHealth Technology EpiTherapeutics ApS is a holding company that develops cancer drugs based on research in the field of epigenetics. Its development programs are focused on enzymes involved in the regulation of transcription in cancer - current programs target histone demethylases and methyltransferases. The firm's regulation is commonly used for post-translational covalent modifications of histones and other chromatin-remodeling complexes, which determines whether a gene is accessible and hence, expressed or repressed. Its covalent modifications involved in epigenetic regulation include deoxyribonucleic acid methylation, histone acetylation, and histone methylation. The company was founded by Kristian Helin, Paul Andreas Compare Cloos, Jesper Aagaard Christensen, Karl Agger, and Klaus Hansen on September 18, 2008 and is headquartered in Greve, Denmark. | Biotechnology | Founder | |
Qiagen AG
 Qiagen AG Medical SpecialtiesHealth Technology Qiagen AG manufactures biological products for purification, transfection, and amplification of nucleic acid and proteins. The company was founded on September 15, 1994 and is headquartered in Basel, Switzerland. | Medical Specialties | Chairman | |
QIAGEN Instruments AG
 QIAGEN Instruments AG Medical SpecialtiesHealth Technology QIAGEN Instruments AG engages in the development, production, and distribution of analytical instruments and devices. It also acquires participating interests in firms, as well as acquires and utilizes patents, licenses, and other rights. The company was founded on February 28, 1990 and is headquartered in Hombrechtikon, Switzerland. | Medical Specialties | Chief Executive Officer | |
Lundbeck Pharma A/S
 Lundbeck Pharma A/S Medical DistributorsDistribution Services Lundbeck Pharma A/S markets and sells medicines within Central Nervous System. It specializes in various illnesses and conditions such as depression, Schizophrenia, anxiety, alcohol dependence, and Parkinson's and Alzheimer's diseases. The company was founded on January 1, 1988 and is headquartered in Valby, Denmark. | Medical Distributors | General Counsel | |
| Agilent Technologies Sweden AB | Corporate Officer/Principal | ||
| Scandinavian Society for Psychopharmacology | Corporate Officer/Principal | ||
| Malmö Högskola | College/University | Undergraduate Degree | |
Ossianix, Inc.
 Ossianix, Inc. Pharmaceuticals: GenericHealth Technology Ossianix, Inc. develops single domain antibodies. It develops biotherapeutic products using the versatile single domain VNAR antibody from the shark and also developed highly innovative approaches to target specific cells and tissues such as the brain via the blood brain barrier and peripheral nerve via the neuromuscular junction. The company was founded by Frank S. Walshin, J. Lynn Rutkowski and Corey S. Goodman in 2011 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Generic | Director/Board Member | |
Prexton Therapeutics SA
 Prexton Therapeutics SA Pharmaceuticals: MajorHealth Technology Prexton Therapeutics SA operates as a biopharmaceutical company which develops novel therapeutic compounds as a new treatment for Parkinson’s disease and other brain disorders. The company was founded by Francois Conquet in 2012 and is headquartered in Geneva, Switzerland. | Pharmaceuticals: Major | Founder | |
| QIAGEN Euro Finance (Luxembourg) SA | Finance/Rental/Leasing | Director/Board Member | |
| Qiagen US Finance Holding (Luxembourg) SARL | Director/Board Member | ||
| PEAK-Service Ltd. | Director/Board Member | ||
| Peak-Services France SARL | Chairman | ||
| Peak-Service GmbH | Chief Executive Officer | ||
| Peak Services (UK) Ltd. | Director/Board Member | ||
| Biotech Research & Innovation Centre | Chairman | ||
| Immunovia, Inc. | Chief Tech/Sci/R&D Officer Chief Executive Officer | ||
InnovationsFonden
 InnovationsFonden Investment ManagersFinance InnovationsFonden provides investment services. It invests in entrepreneurs, researchers, and businesses. The company was founded on January 4, 2005 and is headquartered in Copenhagen, Denmark. | Investment Managers | Chief Executive Officer | |
Edvince AB
 Edvince AB BiotechnologyHealth Technology Edvince AB engages in clinical research and development services. It operates as a biotech company that focuses on a new form of emergency treatment for stroke. The company was founded by Lars Ingvar Herbert Edvinsson in 2003 and is headquartered in Lund, Sweden. | Biotechnology | Chairman Director/Board Member | |
SWElife
 SWElife Miscellaneous Commercial ServicesCommercial Services SWElife engages in the development, utilization, and evaluation of innovations in healthcare. The private company is based in Lund, Sweden. | Miscellaneous Commercial Services | Director/Board Member | |
| MONSENSO A/S | Internet Software/Services | Director/Board Member | |
| SCANDION ONCOLOGY A/S | Pharmaceuticals: Major | Director/Board Member Chairman Chairman | |
Invarmex I Sverige AB
 Invarmex I Sverige AB SteelNon-Energy Minerals Invarmex I Sverige AB specializes in the manufacturing of stainless steel pools and pools for spa and wellness environments. The private company is based in Helsingborg, Sweden. With over 40 years of experience, they offer the best technical, flexible, and cost-effective solutions for public environmental, rehabilitation, wellness, recreational, and spa purposes. | Steel | Director/Board Member |
Statistiques
Internationale
| Danemark | 17 |
| Suède | 11 |
| Etats-Unis | 5 |
| Pays-Bas | 5 |
| Luxembourg | 4 |
Sectorielle
| Health Technology | 22 |
| Finance | 6 |
| Consumer Services | 6 |
| Commercial Services | 5 |
| Technology Services | 3 |
Opérationnelle
| Director/Board Member | 73 |
| Corporate Officer/Principal | 50 |
| Chairman | 29 |
| Independent Dir/Board Member | 18 |
| Chief Executive Officer | 18 |
Relations les plus connectées
- Bourse
- Insiders
- Philipp Mathieu
- Connexions Sociétés
